Welcome to FNHA's new website. We appreciate your patience while we continue to add finishing touches. More Info

New Drug for Opioid Agonist Treatment Added to Plan W as Limited Coverage Benefit

May 5, 2020News releasesBenefits

Effective
April 30, 2020, PharmaCare Plan W has added Sublocade™ (buprenorphine) to the
list of Limited Coverage Drugs available to Health Benefits clients. Sublocade™
is a subcutaneous-injection, long-acting formulation of buprenorphine.

Limited
Coverage Drugs, including Sublocade™, require
Special Authority for coverage. Your doctor can
submit a Special Authority request directly to PharmaCare.

If you have
any questions, please call Health Benefits at 1-855-550-5454.​